Literature DB >> 17924236

Causes of death in a post-mortem series of ALS patients.

Philippe Corcia1, Pierre-François Pradat, François Salachas, Gaëlle Bruneteau, Nadine le Forestier, Danielle Seilhean, Jean-Jacques Hauw, Vincent Meininger.   

Abstract

Death represents the main hallmark of amyotrophic lateral sclerosis (ALS). Despite its importance in clinical care and phase III trials, many uncertainties remain on the cause of death due to the lack of post-mortem verifications. To provide a more robust approach to these causes, we performed a retrospective pathological study on a large cohort of patients. 100 ALS patients referred for a deterioration of their clinical condition and who died in the ALS clinic of Salpétrière had a complete macroscopic and microscopic post-mortem analysis. The clinical causes of death reported on medical records were compared to the results of autopsy. The concordance between clinical and pathological conclusions was insufficient (20%) to consider clinical assessment as a reliable marker of causes of death. At autopsy, broncho-pneumonia and pneumonia were the main causes of death. Heart failure, representing 10% of deaths, was two times more frequent in bulbar than in spinal ALS. Pulmonary embolism representing 6% of death was exclusively found in spinal onset patients and is related to lower limbs disability. An effort has to be made for a better understanding of the causes of deterioration of ALS patients. A more proactive attitude to treat respiratory infections could have a significant impact on survival.

Entities:  

Mesh:

Year:  2008        PMID: 17924236     DOI: 10.1080/17482960701656940

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  41 in total

1.  High frequency spinal cord stimulation-New method to restore cough.

Authors:  K E Kowalski; J R Romaniuk; S W Brose; M A Richmond; T Kowalski; A F DiMarco
Journal:  Respir Physiol Neurobiol       Date:  2016-07-06       Impact factor: 1.931

Review 2.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

3.  Intralingual Administration of AAVrh10-miRSOD1 Improves Respiratory But Not Swallowing Function in a Superoxide Dismutase-1 Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Lori A Lind; Ellyn M Andel; Angela L McCall; Justin S Dhindsa; Katherine A Johnson; Olivia E Stricklin; Christian Mueller; Mai K ElMallah; Teresa E Lever; Nicole L Nichols
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 5.695

4.  Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach.

Authors:  Robert Kueffner; Neta Zach; Maya Bronfeld; Raquel Norel; Nazem Atassi; Venkat Balagurusamy; Barbara Di Camillo; Adriano Chio; Merit Cudkowicz; Donna Dillenberger; Javier Garcia-Garcia; Orla Hardiman; Bruce Hoff; Joshua Knight; Melanie L Leitner; Guang Li; Lara Mangravite; Thea Norman; Liuxia Wang; Jinfeng Xiao; Wen-Chieh Fang; Jian Peng; Chen Yang; Huan-Jui Chang; Gustavo Stolovitzky
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

5.  Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.

Authors:  Marc Gotkine; Denise Kviatcovsky; Eran Elinav
Journal:  Gut Microbes       Date:  2020-06-05

6.  Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients.

Authors:  Maud Maessen; Jan H Veldink; Leonard H van den Berg; Henrike J Schouten; Gerrit van der Wal; Bregje D Onwuteaka-Philipsen
Journal:  J Neurol       Date:  2010-02-11       Impact factor: 4.849

7.  Hypoglossal Motor Neuron Death Via Intralingual CTB-saporin (CTB-SAP) Injections Mimic Aspects of Amyotrophic Lateral Sclerosis (ALS) Related to Dysphagia.

Authors:  Lori A Lind; Erika R Murphy; Teresa E Lever; Nicole L Nichols
Journal:  Neuroscience       Date:  2018-09-01       Impact factor: 3.590

Review 8.  Management of respiratory symptoms in ALS.

Authors:  Orla Hardiman
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

Review 9.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

Review 10.  Ventilatory control in ALS.

Authors:  Nicole L Nichols; J Van Dyke; L Nashold; I Satriotomo; M Suzuki; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-18       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.